News & Filings
APLLTD \u2014 Recent Activity
5 items in the last 14 days
Alembic Pharmaceuticals Ltd (BOM:533573) Q3 2026 Earnings Call Highlights: Strong Revenue ...
Alembic Pharmaceuticals Ltd (BOM:533573) reports an 11% revenue increase, driven by strategic expansions and new product launches, despite facing pricing challenges and margin contractions.
Click to open →
Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes
Feb 5 (Reuters) - Indian drugmaker Alembic Pharmaceuticals on Thursday reported lower third‑quarter profit on Thursday after taking a one-time charge linked to India's new labour code, despite strong
Click to open →
Alembic Pharmaceuticals Ltd (BOM:533573) Q2 2026 Earnings Call Highlights: Strong Revenue ...
Alembic Pharmaceuticals Ltd (BOM:533573) reports robust international growth and strategic acquisitions, despite facing pricing pressures and increased R&D expenses.
Click to open →
India's Alembic Pharma posts quarterly profit jump on strong generics demand
(Reuters) -Indian drugmaker Alembic Pharmaceuticals posted a 20.4% rise in second-quarter profit on Tuesday, aided by strong demand for its generic drugs as well as new launches in its key U.S. market
Click to open →
Alembic Pharmaceuticals acquires UTILITY therapeutics
uUTIs are caused by strains of Proteus mirabilis, Escherichia coli and Staphylococcus saprophyticus.
Click to open →
Get alerts for important filings
Add APLLTD to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.